Investigation of cardiac autonomic and peripheral sensory neuropathy in diabetic and nondiabetic patients with hypertension

Clinical and Experimental Hypertension

Volumn 35, Issue 6, 2013, Pages 465-469

  Legrady, Peter ^a   Bajcsi, Dora ^a   Lengyel, Csaba ^a   Varkonyi, Tamas T ^a   Fejes, Imola ^a   Kempler, Peter ^b   Abraham, Gyorgy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Autonomic; Diabetes; Hypertension; Neuropathy; Sensory

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR REFLEX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; PERONEUS NERVE; SENSORY NEUROPATHY;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84884535685     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.758272     Document Type: Article

References (17)

1. Gerritsen J, Dekker JM, Ten Voorde BJ, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 2001; 24:1793-1798.
2. Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 2001; 23:45-55.
3. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39:1377-1384.
4. Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352:341-350.
5. Zarrelli MM, Amoruso L, Beghi E, Apollo F, Di Viesti P, Simone P. Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. J Epidemiol Biostat 2001; 6:409-413.
6. Cho DY, Mold JW, Roberts M. Further investigation of the negative association between hypertension and peripheral neuropathy in the elderly: an Oklahoma Physicians Resource/Research Network (OKPRN) Study. J Am Board Fam Med 2006; 19:240-250.
7. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older subjects. J Am Board Fam Pract 2004; 17:309-318.
8. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49:95-108.
9. Masson EA, Veves A, Fernando D, Boulton AJ. Current perception thresholds: a new, quick and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32:724-728.
10. Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of the Neurometer in assessing diabetic neuropathy bymeasurement of the current perception threshold. Diabet Med 1994; 11:872-876.
11. Varkonyi TT, Borcso E, Toth F, et al. Severity of autonomic and sensory neuropathy and the impairment of visual-and auditory-evoked potentials in type 1 diabetes: is there a relationship? Diabetes Care 2006; 29:2325-2326.
12. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 1994; 10:339-383.
13. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post myocardial infarction risk stratification. Circulation 1992; 85(Suppl.):177.
14. Kempler P, Kerenyi Z, Tamas G. Autonomic neuropathy: comparison of two screening procedures. Diabetologia 1994; 37:1168-1169.
15. Sowers JD, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001; 37:1053-1059.
16. Tuomilehto J, Rastenyte D, Birkenhager WH, et al. Effects of calcium channel blockers in older patients with diabetes and systolic hypertension. N Engl Med J 1999; 340:677-684.
17. Gasowski J, Birkenhager WH, Staessen JA, de Leeuw PW. Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial. Cardiovasc Drugs Ther 2000; 14:49-53.